Our result showed that the expressions of cdc25c, cdc2 and cyclin B1 in HCC cells were down-regulated by SAC treatment in a dose-dependent manner, indicating SAC may delay S phase progression to G2/M phase of HCC cells through suppression of cell cycle regulators. This evidence concerns the gene ADCY10 and hepatocellular carcinoma.